Home
Conditions
Neoplasms, Germ Cell and Embryonal

Clinical trial condition

Neoplasms, Germ Cell and Embryonal

Explore clinical trials studying Neoplasms, Germ Cell and Embryonal. Study availability and eligibility vary by location and protocol.

6,099 public trials 1,231 recruiting studies

Refine in advanced search Browse all conditions

Neoplasms, Germ Cell and Embryonal trial results

Recruiting

A Phase I Clinical Trial of a mRNA Vaccine for Recurrent or Progressive High-grade Glioma

NCT07306299

Conditions: Glioma, Glioma, High Grade, Neoplasms, +6 more
Locations: Room 521, Building 12, Jiefang Road Campus, The Second Affiliated Hospital of Zhejiang University School of Medicine Hangzhou, Zhejiang, China

View Trial Details

Recruiting

GPC2 CAR T Cells for Relapsed or Refractory Neuroblastoma and Metastatic Retinoblastoma

NCT05650749

Conditions: Eye Diseases, Eye Diseases, Hereditary, Eye Neoplasms, +18 more
Locations: Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States

View Trial Details

Recruiting

PET-imaging of Two Vartumabs in Patients With Solid Tumors

NCT06645808

Conditions: Astrocytoma, Bladder Carcinoma, Breast Cancer, +66 more
Locations: University Medical Center Groningen (UMCG) Groningen, Provincie Groningen, Netherlands

View Trial Details

Recruiting

Study of hALK.CAR T Cells for Patients With Relapsed/Refractory High-risk Neuroblastoma

NCT06803875

Conditions: High-risk Neuroblastoma, Neoplasms, Neoplasms by Histologic Type, +10 more
Locations: Boston Children's Hospital Boston, Massachusetts, United States

Dana-Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Recruiting

Allogeneic Expanded Gamma Delta T Cells With GD2 Chemoimmunotherapy in Relapsed /Refractory Neuroblastoma or Refractory/ Relapsed Osteosarcoma

NCT05400603

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Bone Tissue, +16 more
Locations: Children's Healthcare of Atlanta Atlanta, Georgia, United States

View Trial Details

Recruiting

A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas.

NCT06022029

Conditions: Bites and Stings, Bladder Cancer, Breast Diseases, +72 more
Locations: California Research Institute Los Angeles, California, United States

BRCR Global Tamarac, Florida, United States

Gabrail Cancer Center Research Canton, Ohio, United States

Ohio State University Columbus, Ohio, United States

View all 16 locations

View Trial Details

Recruiting

Nutritional Status Assessment in Adult Patients Followed for Gastroenteropancreatic Neuroendocrine Tumors at Strasbourg University Hospital

NCT07302100

Conditions: Gastro-enteropancreatic neuroendocrine tumor, Gastroenteropancreatic Neuroendocrine Tumor, Neoplasms, +5 more
Locations: Service d'Endocrinologie, Diabétologie, Nutrition - CHU de Strasbourg - France Strasbourg, France

View Trial Details

Recruiting

Predictive Factors of Complete Response to Immunotherapy in Metastatic Melanoma: a Single-center Retrospective Study Between 2013 and 2021

NCT07302607

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +10 more
Locations: Service de dermatologie - Réanimation - CHU de Strasbourg - France Strasbourg, France

View Trial Details

Recruiting

A Study of GC101 TIL in Advanced Melanoma

NCT06703398

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: Beijing Cancer Hospital Beijing, China

View Trial Details

Recruiting

Atezolizumab and Pre-Surgical Brain Radiation Therapy for Glioblastoma Multiforme

NCT05423210

Conditions: Astrocytoma, Glioblastoma, Glioblastoma Multiforme, +8 more
Locations: Stony Brook University Hospital Stony Brook, New York, United States

View Trial Details

Neoplasms, Germ Cell and Embryonal

Neoplasms, Germ Cell and Embryonal trial results

Related conditions